Table 2.

Clinical studies of recombinant human erythropoietin (rHuEpo) in patients with myeloma and lymphoma.

AuthorYearNo. PatientsTreatment Response %Control Response %
* indicates studies where only patients with myeloma were investigated 
Ludwig (*) 1990 13 85  
Cazzola 1995 146 61 
Osterborg 1996 121 60 24 
Dammaco (*) 2001 145 58 
AuthorYearNo. PatientsTreatment Response %Control Response %
* indicates studies where only patients with myeloma were investigated 
Ludwig (*) 1990 13 85  
Cazzola 1995 146 61 
Osterborg 1996 121 60 24 
Dammaco (*) 2001 145 58 
Close Modal

or Create an Account

Close Modal
Close Modal